July 23, 2007 -- Early in July, the government of China set out its ambitious five-year goals for the development of biotechnology. The aim of the initiative is to make China a biotech powerhouse by 2020, increasing biotech revenues to a full 4% of Chinese GDP at that time. These are aggressive plans. To get to that point, China will build on its base of independent innovation, combining it with cooperation with international biotech. Its guiding principle for growth, according to the document, is: “Led by the market, supported by the government.” More details...
